NNNneka Nwachukwu

Nneka Nwachukwu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nneka Nwachukwu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maternal and fetal outcomes in sickle cell disease: impact of anemia and prophylactic transfusion

    by Abraham Attah, Nneka Nwachukwu, Mohamad Ali Tfaily, Maureen Njoku, Tarun Aurora, Justin Yoo, Morgan McLemore, Ross Fasano, Fuad El Rassi

  • Open Access

    Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS‐IT)

    by Caitlin O'Neill, Nneka Nwachukwu, Maria Vergara‐Lluri, Ashley Hagiya, Casey L. O'Connell

    Background: Clonal cytopenia of undetermined significance (CCUS) is defined as somatic mutations of myeloid malignancy-associated genes in the blood or bone marrow with one or more persistent unexplained cytopenias that do not meet diagnostic criteria for a defined myeloid neoplasm. CCUS with isolated thrombocytopenia (CCUS-IT) is rare.Methods: This is a retrospective case series of patients with prolonged isolated thrombocytopenia, a pathogenic mutation on a myeloid molecular panel, and a bone marrow biopsy with morphologic atypia below the WHO-defined diagnostic threshold for dysplasia.Results: Five male patients were identified with a median age at CCUS-IT diagnosis of 61 years (56-74). Median duration of thrombocytopenia prior to CCUS-IT diagnosis was 4 years (3-12), and median platelet count at CCUS-IT diagnosis was 41 x 10(3)/mu L (26-80). All patients had megakaryocytic hyperplasia and megakaryocytes with hyperchromasia and high nuclear-cytoplasmic ratio. Pathogenic SRSF2 mutations were identified in all 5 patients with median variant allele frequency of 36% (28%-50%). Three patients were treated with IVIg and/or steroids with no response; one of three responded to thrombopoietin receptor agonists. Three patients progressed to MDS and one to AML.Discussion: We describe the clinicopathological features of CCUS-IT which can mimic immune thrombocytopenia.